ZURICH, April 22 (Reuters) - Roche, the world's biggest maker of cancer drugs, reported a 3 percent rise in sales in the first quarter on Wednesday, with growth held back by a strong Swiss franc.
The Basel-based firm said sales in the first three months rose to 11.833 billion Swiss francs ($12.40 billion) from 11.496 billion year-ago. This beat analyst views, which averaged 11.492 billion in a Reuters poll.
Also read: Danish credit card sales rise 2.2 pct in Dec
16:50 Goldman Sachs, Citigroup earnings confirm Trump effect on banks18
12:23 Morgan Stanley beats, has a record-breaking quarter for wealth management17
06:13 Pound quivers near three-month low, stocks weak before May's Brexit stance speech19
13:48 Wells Fargo Profit Falls 5.4% as Mortgage Revenue Declines25